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Abstract
Background—Solar elastosis adjacent to melanomas in histologic sections is regarded as an
indicator of sun exposure although the associations of ultraviolet (UV) exposure and phenotype with
solar elastosis are yet to be fully explored.
Methods—The study included 2,589 incident primary melanoma patients with assessment of
histologic solar elastosis in the population-based Genes, Environment, and Melanoma study.
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Ambient erythemal UV (UVE) at places of residence and sun exposure hours, including body site-
specific exposure, were collected. We examined the association of cumulative site-specific and non
site-specific sun exposure hours and ambient UVE with solar elastosis in multivariable models
adjusted for age, sex, center, pigmentary characteristics, nevi and, where relevant, body site.
Results—Solar elastosis was associated most strongly with site-specific UVE (OR for top exposure
quartile, 5.20; 95% CI, 3.40-7.96; P for trend <0.001) and also with site-specific sun exposure (OR
for top quartile, 5.12; 95% CI, 3.35-7.83; P for trend <0.001). Older age (OR at >70 years, 7.69; 95%
CI, 5.14-11.52); P trend < 0.001) and having more than 10 back nevi (OR, 0.77; 95% CI, 0.61-0.97;
P = 0.03) were independently associated with solar elastosis.
Conclusion—Solar elastosis had a strong association with higher site-specific UVE dose, older
age and fewer nevi.
Impact—Solar elastosis could be a useful biomarker of lifetime site-specific UV. Future research
is needed to explore whether age represents more than simple accumulation of sun exposure and the
reason that people with more nevi may be less prone to solar elastosis.
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Introduction
Melanoma risk is positively associated with intermittent sun exposure and may be modestly
inversely associated with a high continuous pattern of sun exposure (1). Solar elastosis, which
is generally considered to be a biomarker for cumulative sun exposure, is frequently found
adjacent to melanoma in histologic sections and is available for assessment by pathologists.
The distinguishing feature of histologic solar elastosis is accumulation of abnormal elastotic
fibers in the upper and middle dermis, which may be related to activation of the human elastin
promoter by ultraviolet (UV) radiation (2) or to an influx of neutrophils that diffuse to the
dermis in response to cytokine production after UVB exposure and degrade elastin (3). In albino
hairless mice, the UV erythema spectrum was the most predictive for elastosis quantified by
computerized image analysis (4). The importance of better understanding the relationship of
age, sun exposure behavior and patient phenotype with solar elastosis among melanoma and
other skin cancer patients is underscored by the use of solar elastosis as a biomarker in
investigations of melanoma etiology (5-8) and outcome (9-13).
Recent epidemiological studies have explored environmental and personal determinants of skin
damage, including whether there are separate effects of chronological aging and cumulative
sun damage. These studies included people with BCC or SCC (14), melanoma (5) or were
drawn from the general population (15) and examined either histologic solar elastosis (5,14)
or silicone cast score (5). While severe solar elastosis was found to occur more frequently on
more heavily sun-exposed sites, no particular phenotypic determinant was identified in
association with sun damage and only one study sought to identify the most predictive measure
of sun exposure (14).
The GEM study was able to estimate cumulative UV dose at the site of the melanoma for all
participants by integrating reported site-specific sun exposure behavior with estimated ambient
UV irradiance at residential locations throughout life. In addition to the personal sun exposure
histories, a range of pigmentary characteristics for patients and pathology information for the
melanomas was available. In this paper, we aim to identify one or more measurements of sun
exposure and the phenotypic or other personal characteristics that best predict histologic solar
elastosis adjacent to the melanoma in incident primary cutaneous melanoma patients.
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The participants in this study were patients with incident first or subsequent primary cutaneous
melanoma diagnosed from 1998 through 2003 in the Genes, Environment, and Melanoma
(GEM) Study (16-18). GEM participants were ascertained from eight population-based cancer
registries: two in Australia (New South Wales, Tasmania), two in Canada (British Columbia,
Ontario), one in Italy (Torino), and three in the USA (Orange and San Diego Counties in
California, New Jersey, and North Carolina).
The study protocol was approved by the Institutional Review Board (IRB) at the coordinating
center, Memorial Sloan-Kettering Cancer Center, as well as the IRBs at each of the participating
institutions. Physician approval was sought prior to contacting eligible participants, and all
study participants provided informed consent. A total of 3,289 patients with incident primary
cutaneous melanoma were enrolled from the eight centers. The participation rate was 53%,
and participants tended to be slightly younger and were more likely to be female compared
with the entire ascertained population (17).
Each participant provided informed consent to obtain diagnostic slides of their melanoma for
a standardized pathology review. Expert dermatopathologists scored adjacent solar elastosis
on the same slides as the melanomas using a grading system (absent, mild/moderate, or severe)
that correlated approximately to the chronic sun damage (CSD) levels proposed by Landi et
al. (8). The kappa statistic using the three categories was 0.64 for scoring solar elastosis in a
test set of 19 sections by three dermatopathologists who individually scored 70%, 20% and
10% of the total slide collection. For the analyses in this report, solar elastosis was grouped as
2 categories, present (mild, moderate, severe elastosis) versus absent.
Phenotypic variables were assessed by items in a self-administered questionnaire for
participant’s natural hair color as a teenager, eye color, and skin color on the inside of the upper
arm (16), and instructions for a count of nevi (moles) on the back, which, for analysis, were
categorized as 0-10 and more than 10. Questions in a telephone interview asked for propensity
to burn on first exposure to sunlight in summer in 4 categories as ‘no sunburn’, ‘mild burn then
peel’, ‘painful burn then peel’, ‘severe burn with blistering’ and ability to tan on repeated
exposure to sunlight in 4 categories as ‘go very brown and deeply tanned’ to ‘get no suntan or
get freckled only’. Questions asked the number of each of painful and blistering sunburns at
each decade of age in each of the warmer and cooler months and whether the melanoma site
was usually burnt on these occasions; for analysis, these were dichotomized as any versus none.
UV Measures
Each participant was asked in the telephone interview for his or her sun exposure hours in the
warmer and cooler months of each decade of life (ages 10, 20, 30, and so on) up to his or her
last completed decade of age. The warmer months in the Northern hemisphere were April-
September and the cooler months October-March and the opposite for the Southern
hemisphere. To estimate total exposure hours for a typical week, the hours were summed for
outdoor hours reported between 9am and 5pm on work or school days and on non-working
days across warmer and cooler months. Additional questions at each decade of age asked for
the frequency of clothing coverage of the melanoma site and frequency of wearing sunscreen
on the site when outdoors in the warmer and cooler months. The interview also sought a lifetime
history from age 15 of hours spent in beach and water activities, which were known to be
strongly associated with melanoma risk (16); exposure hours were summed for each age
interval and the appropriate hours assigned to each decade of age. To estimate site-specific
total sun exposure hours at each decade of age, we multiplied reported outdoor hours by the
frequency of clothing coverage as follows: by 0 (always or almost always covered), 0.25 (not
always but more than half the time), 0.50 (about half the time), 0.75 (less than half the time),
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or 1.00 (never or hardly ever). Total site-specific sun exposure hours were summed from age
5 and analyzed in categories defined by quartiles of subjects ranked in order by exposure. A
measure of sunscreen use to the site was simply dichotomized as ever use or never use.
Using residential locations for each participant, ambient UV irradiance values were calculated
for the warmer and cooler months at each decade of age. Erythemal UV (UVE) irradiances
were calculated as wavelength integrated spectral irradiance between 250 and 400 nm,
weighted by the Commission Internationale de l’Eclairage erythemal sensitivity function
(19), which gives greater weight to shorter wavelengths. The tropospheric UV-visible model
‘TUV’ (20) was used to calculate daily, location-specific irradiances as a function of solar
zenith angle, ozone column, and surface elevation, as described by Lee-Taylor and Madronich
(21). The model used a discrete ordinates method (22), and a pseudo-spherical correction
(23). Corrections for variations in the Earth-Sun distance and for cloud cover (24) were applied.
Ozone column and cloud reflectivity data were obtained from the satellite-borne Total Ozone
Mapping Spectrometer (25-27) Version 7, for November 1978 to June 2000. Location specific
UVE, UVA (320 - 400 nm unweighted) and UVB (280 - 320 nm unweighted) irradiance
estimates from the 1978 to 1989 climatology were applied to all participant exposure dates
before 1990, and values from the 1990 to 2000 climatology were applied to exposure dates
from 1990 onward.
We estimated a cumulative site-specific UV dose for each of UVE, UVA and UVB as the total
ambient UV for an assumed average 8 hours a day multiplied by the proportion of total sun
exposure hours for which each participant reported exposure of the site. The seasonal values
for warmer months and cooler months were combined for an annual dose and totaled over a
lifetime from age 5. UVE, UVA and UVB were all highly correlated (R2 > 0.99), although
ambient UVB irradiance is more sensitive to the slant ozone column amount than is ambient
UVA. Thus in this report, we present the analyses for UVE alone. The median and inter quartile
range (IQR) for cumulative site-specific UVE in participants in each GEM center is presented
in Figure 1. Site-specific beach and water UVE dose was calculated in a similar fashion to total
dose, substituting beach and water hours for total outdoor hours.
Statistical Analysis
Age in these analyses was the patient’s age at diagnosis of the melanoma for which the
dermatopathologist scored solar elastosis in adjacent skin. GEM-wide quantiles were used in
these analyses to categorize sun exposure variables into quarters of exposure for presentation
in the Tables and into eighths for presentation in Figure 2, using cut points based on the
exposure distribution in all participants. We examined the association of demographic,
phenotypic and sun exposure variables with solar elastosis and estimated odds ratios (ORs)
and 95% confidence intervals (CI) for the presence of solar elastosis with reference to none,
calculated in logistic regression models adjusted for age as a continuous variable, sex, and
study center which was included as a covariate to adjust for differences in reviewing
pathologists and percentages of diagnostic slides available in different centers. Tests for linear
trend used the Wald test and modeled each covariate as a single continuous variable. All
significance tests were two-sided. SAS (SAS Institute, Cary, NC, USA) version 9.2 was used
for all analyses.
We assessed the strength of the association between solar elastosis and total reported hours of
sun exposure, total site-specific hours (when the body site was exposed), ambient UVE at
residential locations, total site-specific UVE (that is, integrating reported sun exposure
behavior and UVE), each in quartiles with the lowest quartile as the reference, and site-specific
beach and water UVE in exposure tertiles with no exposure as the reference. Site-specific hours
and UVE were also modeled as continuous variables, and we present the odds per 1000 hours
and per megajoule per meter2 (MJ/m2) of exposure, respectively. The effect of age was
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examined in separate analyses as a categorical and a continuous variable. Before modeling
with the continuous variables, we confirmed that there was a linear relationship with solar
elastosis by plotting each variable in turn against the log odds of solar elastosis (25). The
approach to assessing sun exposure effects was to model each sun exposure variable with
adjustment for age, sex, center and to include as covariates the phenotypic characteristics back
nevi, hair, eye and skin color, ability to tan and propensity to burn. Models for site-specific
sun exposure also included a four-category variable for body site of the melanoma as head and
neck, arms, legs, and trunk. To explore the extent to which age was an independent correlate
of solar elastosis, we compared the estimates for age adjusted only for sex and center and when
included in the multivariable model of sun exposure and phenotypic characteristics.
In addition to examining the size of any change in odds for solar elastosis and its statistical
significance, we used the Akaike information criterion (AIC) to compare models and select
the best fitting model to explain the observed data, given the candidate set of models (28). We
calculated the corrected AIC (AICc) values, which include a bias adjustment for the number
of parameters relative to the sample size, and considered the best model as the one with the
smallest AICc.
Results
Of the 3,289 participants with incident primary melanomas in the GEM study, 2,746 (83.5%)
had slides available for review. After pathology slide review, participants were excluded if
solar elastosis was not scored due to insufficient adjacent tissue (N = 95) or if the lesion was
judged not to be melanoma by the reviewing pathologist (N = 62). The 2,589 (94.3% of 2,746)
melanomas included had histologic solar elastosis adjacent to their melanoma scored as absent,
mild-moderate or severe; 1,805 (69.7%) had solar elastosis present. The mean age of these
2,589 participants was 58.9 years and 56.4% were male. Most sites of melanoma were on the
trunk (43.0%), while the lower extremities (19.8%), upper extremities (18.5%) and head and
neck (18.1%) had approximately equal proportions; site was unknown for 0.6%.
Risk of solar elastosis increased substantially with age to OR, 11.91 at 70+ years, with reference
to 11-40 years (Table 1) and the OR for each year of age was 1.05 (95% CI, 1.04-1.06). More
men than women had solar elastosis (59.6% vs. 49.0%) although the OR for solar elastosis in
men, relative to women, was close to 1.0 when adjusted for age and study center. The odds for
solar elastosis by tertile of age were reasonably similar for men and women together and
separately although the increase with age was steeper in women than men (Table 1; P for
interaction 0.05). Solar elastosis was more common on the head and neck and arms than the
trunk or legs (P < 0.001) (Table 1).
Dark hair (OR, 1.38; 95% CI, 1.08-1.77) and light eye color (OR, 1.37; 95% CI, 1.04-1.80)
showed the strongest evidence of a positive association with solar elastosis when all phenotypic
variables were fitted together in one model adjusted for age, sex and center. There was weaker
evidence that odds of solar elastosis increased with red hair (OR=1.21) and skin that sunburned
with blistering (OR=1.47) (Table 2). When site-specific UVE dose was also included in the
multivariable model, the effects of hair and eye color weakened and there was evidence of a
stronger trend in the odds for solar elastosis as tanning ability decreased or sunburning
increased (Table 2). The effects of the pigmentary variables were substantially similar when
examined in a multivariable model of all pigmentary variables (as in Table 2) and when each
variable was examined separately adjusted only for age, sex and center (results not shown).
Having >10 nevi on the back, relative to <10, reduced the odds of solar elastosis (OR, 0.80;
95% CI 0.65-0.98; P value = 0.03) and was little changed when adjusted for pigmentary
variables except the P value was 0.07 (data not shown). The addition of site-specific UVE dose
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caused the effect of back nevi to strengthen a little to OR, 0.77 (95% CI, 0.61-0.97) for >10
nevi (P = 0.03). In additional analyses, we found that the reduced odds for solar elastosis
associated with the nevus propensity was mainly present for the trunk, arms and legs (OR,
0.75; 95% CI 0.59-0.96; P = 0.02) and was not at all evident for the head and neck (OR, 1.12;
95% CI 0.36-3.49; P = 0.84), but the P value for interaction was 0.61.
Age was strongly and independently associated with elastosis in a model including site-specific
UVE, phenotypic variables and back nevi. The addition of these variables, however, reduced
the odds for age by 1% for each year of age from OR, 1.06 to OR, 1.05 (95% CI 1.04-1.06)
and by 35% at 70 years and older from OR, 11.91 to OR, 7.69 (95% CI 5.14-11.52), relative
to 11-40 years, for men and women together and somewhat more in women (−40%) than men
(−25%) of this age.
Solar elastosis was associated most strongly with estimates of cumulative sun exposure to the
body site. Site-specific sun exposure hours increased the odds for solar elastosis to an OR of
5.12 for the top exposure quartile (Q4; P value for trend < 0.001; Table 3) and the OR for the
continuous measure was 1.05 (95% CI, 1.03-1.06; P < 0.001) for each 1000 site-specific hours.
Inclusion of ambient UVE in this measure to give site-specific UVE dose increased the OR to
5.20 for Q4 (Table 3) and the OR for the continuous measure was 1.11 (95% CI, 1.08-1.14;
P < 0.001) per MJ/m2. Total outdoor hours without consideration of exposure of the body site
or UVE increased the odds for solar elastosis to an OR of 2.13 for Q4 (P value for trend <
0.001) while cumulative ambient UVE, as a non-specific measure based only on places of
residence, had no evident association with solar elastosis (OR, 1.29 for Q4; P for trend = 0.49)
although the inclusion of center as a covariate to account for different pathology reviewers in
different centers would have substantially limited between subject variation in UVE in this
analysis. We also examined site-specific UV dose for hours spent in beach and water activities
as a measure of recreational sun exposure. The odds for the highest exposure tertile, with
reference to no beach and water activities, was OR, 2.37; 95% CI 1.70-3.30; P for trend <0.001.
All sun exposure models were adjusted for age, sex, center and all phenotypic variables; site-
specific measures were also adjusted for body site.
Site-specific UVE appears to be the best predictor of solar elastosis in these data. For exposure
in quartiles (Table 3), the AICc was lowest for site-specific UVE (AICc = 2006), although little
different to the value for site-specific sun exposure hours (AICc = 2007). Total sun exposure
hours without site specificity did not fit the data well (AICc = 2279). The evidence that site-
specific UVE was the best measure of UV exposure was stronger when exposure measures
were modeled as continuous variables (AICc = 1994 for site-specific UVE, 1999 for site-
specific exposure hours and 2278 for total exposure hours only). This hierarchy of cumulative
sun exposure measures is clearly evident when ORs for exposure in 8 categories are plotted
graphically for all body sites together (Figure 2).
In separate analyses by body site, the odds for solar elastosis were high for site-specific UVE
to the head and neck (OR, 1.70; 95% CI, 0.26-11.13 for Q2; OR, 4.13; 95% CI, 0.71-24.14 for
Q3; OR, 17.95; 95% CI, 2.52-128.15 for Q4; P = 0.002) while the odds for the trunk, arms and
legs were overall similar to the estimates in all participants (OR, 1.70; 95% CI, 1.26-2.30 for
Q2; OR, 2.24; 95% CI, 1.60-3.12 for Q3; OR, 4.88; 95% CI, 3.13-7.62 for Q4; P < 0.001). The
P for interaction by body site was 0.23. Almost all lesions on the head and neck (94%) were
positive for solar elastosis and most (59%) were rated as severe. After excluding head and neck
lesions, the estimates for exposure categorized in eighths were very similar to those presented
for all lesions in Figure 2. All models were adjusted for age, sex, center and phenotypic
characteristics.
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Sunburn history showed no evidence of an association with solar elastosis in separate analyses
of any site-specific painful sunburn (OR, 1.02; 95% CI, 0.79-1.32; P = 0.88) or blistering
sunburn (OR, 0.95; 95% CI, 0.70-1.31; P = 0.77) relative to none in each case. Site-specific
sunscreen use similarly had no apparent association with solar elastosis (OR for ever use, 1.18;
95% CI, 0.94-1.48; P = 0.15). In separate analyses of site-specific UVE in users and non-users
of sunscreen on the site, ORs in users were lower (OR, 1.32; 95% CI, 0.89-1.98 for Q2; 2.22;
95% CI, 1.40-3.53 for Q3; 4.53; 95% CI, 2.40-8.53 for Q4; P for trend <0.001) than in non-
users for each exposure category, especially Q4 (OR, 2.06; 95% CI, 1.21-3.50 for Q2; 2.81;
95% CI, 1.64-4.83 for Q3; 8.47; 95% CI, 4.16-17.23 for Q4; P for trend <0.001) (P for
interaction = 0.09). All analyses were adjusted for age, sex, center and phenotypic variables;
the model for sunburn also included site-specific UVE and body site, and the model examining
site-specific UVE by sunscreen use also included body site.
Discussion
We found that cumulative site-specific UVE dose had a strong positive dose-response
relationship with histologic solar elastosis adjacent to melanomas. Additionally, site-specific
UVE dose was the best of a number of sun exposure measurements in accounting for solar
elastosis, judging by the AIC statistic. We also found that solar elastosis had a strong positive
association with age even after adjusting for cumulative site-specific UVE dose and that
elastosis occurred more frequently in skin on the sun-exposed head and neck and the arms than
on the lesser exposed trunk and legs. Having more than 10 nevi on the back reduced the overall
chance of solar elastosis. In addition to high cumulative sun exposure, our results indicate that
older age and a tendency to fewer nevi were the personal characteristics that increased the
chance of solar elastosis.
The strong positive association of histologic solar elastosis with cumulative sun exposure in
GEM supports similar findings in previous studies that examined histologic solar elastosis in
skin cancer patients (5,14) or photoaging ratings in silicone skin casts in the general population
(15). The link to cumulative exposure was consistent across sunlight environments from high
levels of Queensland sun (5) to low levels in New Hampshire (14), across a wide latitude range
at 270S to 430S (15), and now internationally in our study. All studies measured sun exposure
behavior individually in participants, but only GEM and the New Hampshire study (14) used
site-specific measurements; others used a composite of weekend outdoor hours and residential
UVE (15) or broad categories of cumulative exposure (5). Rates of sun damage were high,
with moderate or severe elastosis in 70% of Queensland (5) and GEM melanoma patients and
90% or more of New Hampshire BCC and SCC patients (14). Australian residents too had high
skin damage scores (3.9 and 4.9 for each hand on a scale of 6) (15). The finding in GEM that
high levels of sun exposure increased the chance of solar elastosis more on the head and neck
than at other body sites was in agreement with studies that directly measured sun exposure
(5,14) or examined tissue (5,12,29) at different body sites. Unlike the very strong and consistent
association with cumulative sun exposure, site-specific lifetime recreational sun exposure
increased the odds for solar elastosis but not strongly in our study and only for intermediate
exposure levels in the New Hampshire study (14) or not significantly in Queensland patients
(5).
Karagas et al. (14) were the first to report the strong association of solar elastosis with
cumulative sun exposure to the site, but did not present results for non-specific measures and
did not incorporate ambient UV, as we did. The strong associations we observed in GEM for
site-specific exposure can be ascribed to reducing exposure misclassification and giving weight
to the environment by incorporating ambient UV and site-specific exposure hours into a single
measure. We have shown that adding environmental UVE to self-reported sun exposure hours
can improve site-specific sun exposure measurement. The results of our study support the use
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of solar elastosis as a biomarker of cumulative sun exposure in epidemiological studies that
collect skin tissue.
The positive correlation of age with solar elastosis agrees with the greater prevalence at older
ages in New Hampshire, especially in women (14), and in Australia (5,15,30). Both age and
cumulative sun exposure were independently associated with solar elastosis in our study and
potentially also in the US and Australian studies, which both mention that adjusting for age
did not weaken the relationship with cumulative sun exposure. They do not, however, report
estimates for age when adjusted for sun exposure (14,15). The strong association with age may
be due to a contribution of intrinsic aging to solar elastosis or to the accumulation of UV
exposure with age that is not fully addressed by adjusting for sun exposure in the
epidemiological studies, or to other unmeasured variables. We expect that future studies,
perhaps incorporating site-specific UVE measurements, will attempt to disentangle the
contributions of aging and sun exposure in causing sun-related conditions such as solar elastosis
or skin cancer.
Our observation that a high nevus count on the back in the GEM study reduced the odds of
solar elastosis by 20% is consistent with the Queensland study in which there was some
evidence that greater numbers of nevi may have reduced the odds for solar elastosis, based on
patient numbers (5), and the Australian general population study in which having any nevi
reduced the odds of sun damage to 0.39 (95% CI, 0.23-0.66) (15).
Sun exposure is known to be positively associated with both nevus count (31) and presence of
solar elastosis. Thus we could reasonably expect the nevus propensity to be associated with a
greater likelihood of solar elastosis. Instead, the available evidence indicates that solar elastosis
was less likely in the presence of a higher nevus count (5) even after controlling for sun
exposure and sun sensitivity (see Table 3 and (15)). Since nevi are genetically determined
(32-34), there may be a genetic component to the resistance to solar elastosis. In our study, the
reduced odds ratio for solar elastosis associated with the nevus propensity was due mainly to
solar elastosis on the trunk, arms and legs. We suggest that being less prone to solar elastosis
and possibly other forms of sun damage such as solar keratoses (14) may be another element
in the dual pathway hypothesis under which a person predisposed to nevi requires less sun
exposure to develop melanoma (35,36). The hypothesis does not currently specify an element
of resistance to sun damage in this pathway.
Our results for phenotype are moderately supportive of the importance of a sun sensitive
phenotype for solar elastosis (15). Reduced tanning ability and a severe sunburn response to
unprotected exposure were each associated with solar elastosis in our study and strengthened
on adjustment for sun exposure, although not significantly so, but there was no strong and
consistent effect of skin or hair color. Similarly, tanning and skin color (assessed by
colorimeter) had no evident effect either way on solar elastosis in BCC and SCC patients
(14) while the Queensland study did not report on pigmentary characteristics (5). There may
not yet be sufficient evidence for the role of host phenotype in the development of skin damage.
The lack of prominence for phenotype, especially fair skin, in association with solar elastosis
in studies of normal skin in skin cancer patients may be a consequence of most patients having
fair skin (88% had fair or very fair skin in GEM).
Sunburn is considered to be a measure of intermittent sun exposure. Unlike the strong
relationship with cumulative site-specific UVE, sunburn had no evident association with solar
elastosis in our study or the New Hampshire study (14). A possible explanation is that people
who burn readily may accumulate less time in the sun and thus are less likely to experience
marked solar elastosis. Having sunburns or blistering sunburns, however, had a two-fold or
more increased odds of sun damage after adjusting for cumulative whole body sun exposure,
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but not pigmentary characteristics, in the Australian general population study (15). There is no
ready explanation for this inconsistency. Possibilities include differences in the nature of skin
damage when measured by skin cast or histologic assessment, differences due to the body site
examined since the back of the hand is known to be less susceptible to skin cancer, or the
possibility of confounding with an underlying genetic component (37) that is more common
in people with skin cancer than in the general population. Another possibility is that the high
UV environment of the Australian population offered a greater opportunity to experience
sunburn (87% reported any sunburn, 66% blistering sunburn) (15) than in GEM (64% any
sunburn, 45% blistering sunburn) or New Hampshire (57% painful sunburn) (14). We interpret
the lack of an effect of sunburn on solar elastosis in the skin cancer studies as further support
for the contribution of cumulative sun exposure, and not intermittent sun exposure, to solar
elastosis.
Our finding that the risk of solar elastosis was higher for site-specific UVE in people who
reported no sunscreen use on the body site than in users is the first report of an apparently
protective effect of sunscreens against this type of sun damage. It is, however, consistent with
a strong inverse dose-response relationship between amount of sunscreen used regularly and
development of new solar keratoses and remission of existing ones (38), and with prevention
of SCC, but not BCC, by recent use of sunscreens (39).
Among the advantages of this report are the standardized histopathology review by expert
pathologists of all melanoma slides including the scoring of solar elastosis, the study’s large
international population base, accounting for potential confounding by phenotype, and the
detailed sun exposure measurements integrating behavior with objective ambient UV
measurements and restricting exposure to times when the site was exposed to the sun. All
participants had melanoma and were unlikely to be aware of whether they had solar elastosis
or not, thus minimizing the potential for recall bias.
The measures incorporating behavior, however, may have inaccuracies due to error in self-
reported exposure hours over a lifetime. Our site-specific UVE dose may have other sources
of error because it included only exposure hours between 9am and 5pm (up to 15% of ambient
UVE falls outside of 9am- 5pm, see Madronich, 1993 (40)) and could make no allowance for
variation in ambient UVE irradiance between 9am and 5pm.
Variables used in the modeling were not predictive of missing data for solar elastosis, except
for center location, which was mainly due to the different percentages of participants with
diagnostic slides available for review. Although all study participants had melanoma and thus
our results might be considered not to apply more widely, the consistency of our results with
the strong association of cumulative UVR dose and skin damage reported in the general
population (15) supports their wider applicability.
We found that solar elastosis was strongly associated with cumulative lifetime site-specific
UV dose. This relationship is biologically plausible. Our study was the first to demonstrate the
extent of the improvement gained in evaluating the relationship between sun exposure and
solar elastosis by using site-specific measurements and, additionally, the stronger effect
estimates that resulted from accounting for ambient UV. We conclude that solar elastosis could
be a useful biomarker of cumulative sun exposure in epidemiological studies that collect skin
biopsies. The strong relationship of solar elastosis with age could indicate the possibility of an
explanation other than a simple accumulation of sun exposure over time. Finally, the inverse,
independent relationship with number of nevi may suggest that people with a genetic
predisposition to nevi may be less prone to sun damage. Future studies would usefully include
possible genetic markers of relevance, including any that may be related to solar elastosis.
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Cumulative site-specific UVE dose in MJ/m2: Mean, median and interquartile range
experienced at the body site by participants in GEM centers (NSW, New South Wales; TAS,
Tasmania, Australia; S CAL, Southern California; N CAR, North Carolina; NJ, New Jersey,
BR COL, British Columbia, Canada; ONT, Ontario, Canada; TOR, Torino, Italy). Site-specific
UVE dose was calculated as total ambient UVE (estimated by NCAR for each participant’s
place of residence at each decade of age) for an assumed average 8 hours a day multiplied by
the proportion of total sun exposure hours that the site was exposed for each participant. This
sun exposure measure takes into account both site-specific sun exposure behavior and ambient
UV irradiance.
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ORs for solar elastosis on all body sites in 2,304 GEM participants: cumulative sun exposure
measures in eight ordered categories containing equal numbers of participants in models
adjusted for age, sex, center, pigmentary characteristics and nevi; site-specific exposure also
adjusted for body site (head and neck, trunk, arms, legs). Total hours and site-specific hours
of sun exposure were reported by participants; site-specific UVE was calculated as total
ambient UVE for an assumed average 8 hours a day multiplied by the proportion of total sun
exposure hours that the site was exposed for each participant.
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Table 1
Age, sex and bodysite in relationship to histologic solar elastosis in participants in the GEM study (N = 2,589)
Characteristic




N = 785 N = 1,804 OR*(95% CI)
Sex
 Female 400 728 1.00
 Male 385 1,076 0.99 (0.81-1.21) 0.93
Age
 11-40y 216 162 1.00
 41-50y 185 210 1.78 (1.30-2.43)
 51-60y 181 355 3.50 (2.58-4.76)
 61-70y 102 434 8.18 (5.84-11.45)
 71-97y 101 643 11.91 (8.55-16.59) < 0.001
Age by sex
 Male
  11-50y 141 151 1.00
  51-70y 172 490 3.32 (2.43-4.55)
  71-97y 72 435 7.16 (4.96-10.34) < 0.001
 Female
  11-50y 260 221 1.00
  51-70y 111 299 4.10 (2.97-5.65)
  71-97y 29 208 11.50 (7.18-18.42) < 0.001
Body site
  Trunk/Pelvis 449 665 1.00
  Head/Neck 30 438 9.26 (6.08-14.11)
  Arms 71 409 5.32 (3.84-7.35)
  Legs 229 283 0.99 (0.76-1.29) < 0.001
*
OR for sex adjusted for age (continuous) and study center; ORs for age adjusted for sex and center; ORs for age by sex adjusted for center. ORs for
body site adjusted for age (continuous), sex, and study center.
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Table 3
The relationships between solar elastosis and lifetime cumulative sun exposure measures in participants in the
GEM study (N = 2,304).
Cumulative sun exposure
Solar elastosis Present vs. absent solar elastosis
adjusted for pigmentary characteristics & nevi
Absent Present no yes
N = 697 N =1,607 OR* (95% CI) OR† (95% CI)
Site specific measurement§
Site-specific sun exposure hours
 Quartile 1 262 302 1.00 1.00
 Quartile 2 215 365 1.66 (1.24-2.21) 1.80 (1.34-2.41)
 Quartile 3 171 406 1.69 (1.24-2.31) 1.86 (1.35-2.56)
 Quartile 4 49 534 4.33 (2.87-6.53) 5.12 (3.35-7.83)
  P for trend < 0.001 < 0.001
Site-specific beach and water UVE dose
 None 258 464 1.00 1.00
 Tertile 1 208 328 1.24 (0.93-1.66) 1.32 (0.99-1.78)
 Tertile 2 138 393 1.66 (1.23-2.26) 1.85 (1.35-2.53)
 Tertile 3 104 443 2.06 (1.50-2.83) 2.37 (1.70-3.30)
  P for trend <0.001 <0.001
Site-specific UVE dose
 Quartile 1 265 292 1.00 1.00
 Quartile 2 232 348 1.53 (1.15-2.04) 1.66 (1.24-2.23)
 Quartile 3 154 427 1.91 (1.40-2.61) 2.11 (1.53-2.91)
 Quartile 4 46 540 4.41 (2.91-6.69) 5.20 (3.40-7.96)
  P for trend < 0.001 < 0.001
Non-site specific measurement
Total sun exposure hours
 Quartile 1 276 284 1.00 1.00
 Quartile 2 187 386 1.41 (1.05-1.88) 1.47 (1.10-1.98)
 Quartile 3 143 456 1.66 (1.20-2.29) 1.75 (1.26-2.43)
 Quartile 4 91 481 1.96 (1.34-2.86) 2.13 (1.45-3.12)
  P for trend < 0.001 < 0.001
Ambient UVE
 Quartile 1 322 235 1.00 1.00
 Quartile 2 186 365 1.05 (0.72-1.54) 1.07 (0.73-1.58)
 Quartile 3 120 471 1.12 (0.65-1.93) 1.16 (0.67-2.01)
 Quartile 4 69 536 1.23 (0.59-2.55) 1.29 (0.61-2.70)
  P for trend 0.56 0.49
*
Adjusted for age (continuous) sex, and center.
†
Adjusted for age (continuous), sex, center, pigmentary characteristics (hair, eye and skin color, ability to tan, propensity to burn), and back nevi.
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§
Site-specific sun exposure measures also adjusted for body site of melanoma
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